Analysis of the Ischemia-Modified Albumin as a Potential Biomarker for Cardiovascular Damage in Obst...
Analysis of the Ischemia-Modified Albumin as a Potential Biomarker for Cardiovascular Damage in Obstructive Sleep Apnea Patients with Acute Coronary Syndrome
About this item
Full title
Author / Creator
Resano-Barrio, Pilar , Alfaro, Enrique , Solano-Pérez, Esther , Coso, Carlota , Cubillos-Zapata, Carolina , Díaz-García, Elena , Romero-Peralta, Sofía , Izquierdo-Alonso, Jose Luis , Barbé, Ferran , García-Rio, Francisco , Sánchez-de-la-Torre, Manuel , Mediano, Olga and on behalf of the Spanish Sleep Network
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
Obstructive sleep apnea (OSA) has been identified as a cardiovascular (CV) risk factor. The potential of OSA promoting the synthesis of CV biomarkers in acute coronary syndrome (ACS) is unknown. Ischemia-modified albumin (IMA) has been identified as a specific CV biomarker. The aim of this study was to evaluate the role of IMA as a potential biomar...
Alternative Titles
Full title
Analysis of the Ischemia-Modified Albumin as a Potential Biomarker for Cardiovascular Damage in Obstructive Sleep Apnea Patients with Acute Coronary Syndrome
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10219184
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10219184
Other Identifiers
ISSN
1422-0067,1661-6596
E-ISSN
1422-0067
DOI
10.3390/ijms24109019
